-5%
Tedizolid, the active form of Tezo, inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit of Gram-positive bacteria. This mechanism is unique, making cross-resistance with non-oxazolidinone antibiotics unlikely.
Tezo, an oxazolidinone-class antibacterial, is indicated for treating acute bacterial skin and skin structure infections (ABSSSI) in adults caused by designated susceptible bacteria. Tezo should only be used to treat or prevent infections confirmed or strongly suspected to be caused by these bacteria to help reduce the development of drug-resistant organisms and maintain the efficacy of antibacterial medications.
Use only as prescribed by a registered physician.